ENTPD1 and acute myeloid leukemia: Importantly, dual blockade of A2AR or CD39 in combination with TIGIT exhibits synergistic cytolytic effects in two-thirds of the cell lines, whereas triple blockade markedly enhances NK cell killing efficacy against TF-1 AML cells [162].